Published in Science on January 12, 1996
Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med (2005) 4.65
On the molecular mechanism of chloroquine's antimalarial action. Proc Natl Acad Sci U S A (1996) 3.29
Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Antimicrob Agents Chemother (2002) 3.01
Malaria parasite proteins that remodel the host erythrocyte. Nat Rev Microbiol (2009) 2.62
The role of neutral lipid nanospheres in Plasmodium falciparum haem crystallization. Biochem J (2007) 2.27
Plasma concentrations of parasite histidine-rich protein 2 distinguish between retinopathy-positive and retinopathy-negative cerebral malaria in Malawian children. J Infect Dis (2012) 2.16
Plasmepsin V licenses Plasmodium proteins for export into the host erythrocyte. Nature (2010) 1.97
Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests. Malar J (2010) 1.77
Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria. Antimicrob Agents Chemother (2006) 1.72
Trafficking of plasmepsin II to the food vacuole of the malaria parasite Plasmodium falciparum. J Cell Biol (2004) 1.69
4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob Agents Chemother (1996) 1.65
Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. Biochem J (1999) 1.62
The evolution, metabolism and functions of the apicoplast. Philos Trans R Soc Lond B Biol Sci (2010) 1.55
HDP-a novel heme detoxification protein from the malaria parasite. PLoS Pathog (2008) 1.55
Cooperative domains define a unique host cell-targeting signal in Plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci U S A (2003) 1.53
Speciation and structure of ferriprotoporphyrin IX in aqueous solution: spectroscopic and diffusion measurements demonstrate dimerization, but not mu-oxo dimer formation. J Biol Inorg Chem (2006) 1.45
Hemoglobin degradation in malaria-infected erythrocytes determined from live cell magnetophoresis. FASEB J (2006) 1.31
Hemozoin-generated vapor nanobubbles for transdermal reagent- and needle-free detection of malaria. Proc Natl Acad Sci U S A (2013) 1.28
Formation of the food vacuole in Plasmodium falciparum: a potential role for the 19 kDa fragment of merozoite surface protein 1 (MSP1(19)). PLoS One (2008) 1.18
Crystallization of synthetic haemozoin (beta-haematin) nucleated at the surface of lipid particles. Dalton Trans (2009) 1.17
Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II. Blood (2011) 1.12
Hematin polymerization assay as a high-throughput screen for identification of new antimalarial pharmacophores. Antimicrob Agents Chemother (2000) 1.07
Transdermal Diagnosis of Malaria Using Vapor Nanobubbles. Emerg Infect Dis (2015) 1.06
Mechanism of malarial haem detoxification inhibition by chloroquine. Biochem J (2001) 1.02
Reaction of artemisinin with haemoglobin: implications for antimalarial activity. Biochem J (2005) 1.01
Hemozoin: oil versus water. Parasitol Int (2007) 1.00
Sequence variation does not confound the measurement of plasma PfHRP2 concentration in African children presenting with severe malaria. Malar J (2012) 0.97
Potential biomarkers and their applications for rapid and reliable detection of malaria. Biomed Res Int (2014) 0.96
Positive selection systems for discovery of novel polyester biosynthesis genes based on fatty acid detoxification. Appl Environ Microbiol (1997) 0.96
Malarial hemozoin: from target to tool. Biochim Biophys Acta (2014) 0.96
Antiplasmodial activity of [(aryl)arylsulfanylmethyl]Pyridine. Antimicrob Agents Chemother (2007) 0.95
Simple colorimetric inhibition assay of heme crystallization for high-throughput screening of antimalarial compounds. Antimicrob Agents Chemother (2006) 0.94
The chemical mechanism of beta-haematin formation studied by Mössbauer spectroscopy. Biochem J (1996) 0.93
Cytostatic versus cytocidal activities of chloroquine analogues and inhibition of hemozoin crystal growth. Antimicrob Agents Chemother (2012) 0.91
Copper pathways in Plasmodium falciparum infected erythrocytes indicate an efflux role for the copper P-ATPase. Biochem J (2004) 0.90
Alpha-glucosidase promotes hemozoin formation in a blood-sucking bug: an evolutionary history. PLoS One (2009) 0.90
Plasmodium falciparum Histidine-Rich Protein II Compromises Brain Endothelial Barriers and May Promote Cerebral Malaria Pathogenesis. MBio (2016) 0.89
Involvement of heme in the antimalarial action of chloroquine. Trans Am Clin Climatol Assoc (1998) 0.89
Antimalarial drugs and heme in detergent micelles: An NMR study. J Inorg Biochem (2009) 0.88
Interaction of Plasmodium falciparum histidine-rich protein II with human lymphocytes leads to suppression of proliferation, IFN-gamma release, and CD69 expression. Parasitol Res (2006) 0.87
On the mechanisms involved in biological heme crystallization. J Bioenerg Biomembr (2011) 0.87
A simple and inexpensive haemozoin-based colorimetric method to evaluate anti-malarial drug activity. Malar J (2012) 0.84
Quantitative detection of PfHRP2 in saliva of malaria patients in the Philippines. Malar J (2012) 0.84
The single crystal X-ray structure of β-hematin DMSO solvate grown in the presence of chloroquine, a β-hematin growth-rate inhibitor. J Am Chem Soc (2013) 0.83
Synthetic Hemozoin (β-Hematin) Crystals Nucleate at the Surface of Neutral Lipid Droplets that Control Their Sizes. Cryst Growth Des (2013) 0.82
Phospholipid membrane-mediated hemozoin formation: the effects of physical properties and evidence of membrane surrounding hemozoin. PLoS One (2013) 0.82
Use of a pLDH-based dipstick in the diagnostic and therapeutic follow-up of malaria patients in Mali. Malar J (2011) 0.81
Complex nature of malaria parasite hemoglobin degradation [corrected]. Proc Natl Acad Sci U S A (2013) 0.81
Plasmodium falciparum-infected erythrocytes and beta-hematin induce partial maturation of human dendritic cells and increase their migratory ability in response to lymphoid chemokines. Infect Immun (2011) 0.81
Identification of essential histidine residues involved in heme binding and Hemozoin formation in heme detoxification protein from Plasmodium falciparum. Sci Rep (2014) 0.80
Uptake of proteins and degradation of human serum albumin by Plasmodium falciparum-infected human erythrocytes. Malar J (2003) 0.78
An automated method for determining the cytoadhesion of Plasmodium falciparum-infected erythrocytes to immobilized cells. Malar J (2015) 0.78
2-tert-butyl-8-quinolinamines exhibit potent blood schizontocidal antimalarial activity via inhibition of heme crystallization. Antimicrob Agents Chemother (2007) 0.78
Quantification of labile heme in live malaria parasites using a genetically encoded biosensor. Proc Natl Acad Sci U S A (2017) 0.78
Hemozoin and antimalarial drug discovery. Future Med Chem (2013) 0.77
Malaria theranostics using hemozoin-generated vapor nanobubbles. Theranostics (2014) 0.77
Unsaturated glycerophospholipids mediate heme crystallization: biological implications for hemozoin formation in the kissing bug Rhodnius prolixus. PLoS One (2014) 0.77
Genome-wide transcriptome profiling reveals functional networks involving the Plasmodium falciparum drug resistance transporters PfCRT and PfMDR1. BMC Genomics (2015) 0.76
High-throughput screening and prediction models building for novel hemozoin inhibitors using physicochemical properties. Antimicrob Agents Chemother (2016) 0.75
Individuals living in a malaria-endemic area of Cameroon do not have an acquired antibody response to Plasmodium falciparum histidine-rich protein 2. Malar J (2017) 0.75
Dendrimeric template of Plasmodium falciparum histidine rich protein II repeat motifs bearing Asp→Asn mutation exhibits heme binding and β-hematin formation. PLoS One (2014) 0.75
Effect of Inducers, Incubation Time and Heme Concentration on IC(50) Value Variation in Anti-heme Crystallization Assay. Trop Med Health (2011) 0.75
Characterization of the commercially-available fluorescent chloroquine-BODIPY conjugate, LynxTag-CQGREEN, as a marker for chloroquine resistance and uptake in a 96-well plate assay. PLoS One (2014) 0.75
Antimalarial Activity of Small-Molecule Benzothiazole Hydrazones. Antimicrob Agents Chemother (2016) 0.75
A Multicenter Pivotal Clinical Trial of a Urine Malaria Test (UMT) for the Rapid Diagnosis of Plasmodium falciparum Malaria. J Clin Microbiol (2016) 0.75
A genetically encoded toolkit for tracking live-cell histidine dynamics in space and time. Sci Rep (2017) 0.75
Development of an Immunosensor for PfHRP 2 as a Biomarker for Malaria Detection. Biosensors (Basel) (2017) 0.75
Elasticity in Macrophage-Synthesized Biocrystals. Angew Chem Int Ed Engl (2017) 0.75
Label-Free Direct Electrical Detection of a Histidine-Rich Protein with Sub-Femtomolar Sensitivity using an Organic Field-Effect Transistor. ChemistryOpen (2017) 0.75
Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature (1990) 5.20
Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol (1997) 3.66
On the molecular mechanism of chloroquine's antimalarial action. Proc Natl Acad Sci U S A (1996) 3.29
Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science (1987) 3.25
Evidence for extensive subcellular organization of asparagine-linked oligosaccharide processing and lysosomal enzyme phosphorylation. J Biol Chem (1983) 3.22
Perceived health status and morbidity and mortality: evidence from the Kuopio ischaemic heart disease risk factor study. Int J Epidemiol (1996) 2.73
Identification and characterization of cells deficient in the mannose 6-phosphate receptor: evidence for an alternate pathway for lysosomal enzyme targeting. Proc Natl Acad Sci U S A (1983) 2.67
Plasmodium falciparum maturation abolishes physiologic red cell deformability. Science (1984) 2.51
Beer binging and mortality: results from the Kuopio ischaemic heart disease risk factor study, a prospective population based study. BMJ (1997) 2.40
An iron-carboxylate bond links the heme units of malaria pigment. Proc Natl Acad Sci U S A (1991) 2.36
Antimalarials increase vesicle pH in Plasmodium falciparum. J Cell Biol (1985) 2.27
Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med (1997) 2.06
A set of independent selectable markers for transfection of the human malaria parasite Plasmodium falciparum. Proc Natl Acad Sci U S A (1999) 2.04
Role for the Salmonella flavohemoglobin in protection from nitric oxide. J Biol Chem (1998) 2.02
Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase. EMBO J (1994) 2.00
Malaria parasite exit from the host erythrocyte: a two-step process requiring extraerythrocytic proteolysis. Proc Natl Acad Sci U S A (2001) 1.99
The plasmodium digestive vacuole: metabolic headquarters and choice drug target. Parasitol Today (1995) 1.96
Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med (1998) 1.96
Co-ordinated programme of gene expression during asexual intraerythrocytic development of the human malaria parasite Plasmodium falciparum revealed by microarray analysis. Mol Microbiol (2001) 1.96
Ascaris haemoglobin is a nitric oxide-activated 'deoxygenase'. Nature (1999) 1.93
Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets. Trends Parasitol (2001) 1.90
Hostility and increased risk of mortality and acute myocardial infarction: the mediating role of behavioral risk factors. Am J Epidemiol (1997) 1.89
Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J Clin Invest (1994) 1.84
The phosphorylation of beta-glucuronidase oligosaccharides in mouse P388D1 cells. J Biol Chem (1981) 1.70
ColE1 hybrid plasmids for Escherichia coli genes of glycolysis and the hexose monophosphate shunt. J Bacteriol (1979) 1.67
Anger expression and incident stroke: prospective evidence from the Kuopio ischemic heart disease study. Stroke (1999) 1.53
Predictors of disability retirement. Scand J Work Environ Health (1997) 1.52
Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum. J Biol Chem (1999) 1.43
Hopelessness and 4-year progression of carotid atherosclerosis. The Kuopio Ischemic Heart Disease Risk Factor Study. Arterioscler Thromb Vasc Biol (1997) 1.42
Isolation and functional characterization of the PfNT1 nucleoside transporter gene from Plasmodium falciparum. J Biol Chem (2000) 1.41
Localization of the Plasmodium falciparum PfNT1 nucleoside transporter to the parasite plasma membrane. J Biol Chem (2001) 1.40
Inosine stimulates extensive axon collateral growth in the rat corticospinal tract after injury. Proc Natl Acad Sci U S A (1999) 1.35
Regulation of the Salmonella typhimurium flavohemoglobin gene. A new pathway for bacterial gene expression in response to nitric oxide. J Biol Chem (1998) 1.34
Hypertension incidence is predicted by high levels of hopelessness in Finnish men. Hypertension (2000) 1.29
Studies of the biosynthesis of the mannose 6-phosphate receptor in receptor-positive and -deficient cell lines. J Cell Biol (1983) 1.28
Lysosomal enzyme oligosaccharide phosphorylation in mouse lymphoma cells: specificity and kinetics of binding to the mannose 6-phosphate receptor in vivo. J Cell Biol (1982) 1.27
Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II. J Biol Chem (1997) 1.27
Interaction of workplace demands and cardiovascular reactivity in progression of carotid atherosclerosis: population based study. BMJ (1997) 1.26
Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. Proc Natl Acad Sci U S A (1996) 1.26
Clindamycin activity against chloroquine-resistant Plasmodium falciparum. J Infect Dis (1984) 1.24
A common mechanism for blockade of heme polymerization by antimalarial quinolines. J Biol Chem (1998) 1.23
Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum. Biochem Pharmacol (1992) 1.19
Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism. Blood (1998) 1.18
The structure of Ascaris hemoglobin domain I at 2.2 A resolution: molecular features of oxygen avidity. Proc Natl Acad Sci U S A (1995) 1.15
Biosynthesis of membrane-derived oligosaccharides: a periplasmic phosphoglyceroltransferase. Proc Natl Acad Sci U S A (1981) 1.15
Weight gain and the risk of developing insulin resistance syndrome. Diabetes Care (1998) 1.15
Ascaris hemoglobin gene: plant-like structure reflects the ancestral globin gene. Proc Natl Acad Sci U S A (1992) 1.14
Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole, is active at neutral pH on the host erythrocyte membrane skeleton. J Biol Chem (1999) 1.14
Generation of hemoglobin peptides in the acidic digestive vacuole of Plasmodium falciparum implicates peptide transport in amino acid production. Mol Biochem Parasitol (1997) 1.11
Inoculum effect with chloroquine and Plasmodium falciparum. Antimicrob Agents Chemother (1987) 1.09
Plasmodium protein phosphatase 2C dephosphorylates translation elongation factor 1beta and inhibits its PKC-mediated nucleotide exchange activity in vitro. Mol Microbiol (2001) 1.08
Anticipatory blood pressure response to exercise predicts future high blood pressure in middle-aged men. Hypertension (1996) 1.07
Regulation of Saccharomyces cerevisiae flavohemoglobin gene expression. J Biol Chem (1995) 1.05
A comparison of functional and structural consequences of the tyrosine B10 and glutamine E7 motifs in two invertebrate hemoglobins (Ascaris suum and Lucina pectinata). Biochemistry (1997) 1.03
Pattern of alcohol drinking and progression of atherosclerosis. Arterioscler Thromb Vasc Biol (1999) 1.01
Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II. J Med Chem (1999) 1.01
Kinetic analysis of plasmepsins I and II aspartic proteases of the Plasmodium falciparum digestive vacuole. Mol Biochem Parasitol (1996) 1.00
Acid intracellular vesicles and the cytolysis of mammalian target cells by Entamoeba histolytica trophozoites. J Protozool (1986) 1.00
Identification and characterization of an unusual double serine/threonine protein phosphatase 2C in the malaria parasite Plasmodium falciparum. J Biol Chem (1998) 0.98
Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library. Bioorg Med Chem Lett (1998) 0.97
Expression, characterization, and crystallization of oxygen-avid Ascaris hemoglobin domains. J Biol Chem (1993) 0.92
Endovascular treatment of epistaxis in a patient with tuberculosis and a giant petrous carotid pseudoaneurysm. AJNR Am J Neuroradiol (1995) 0.92
An unexpected 5' untranslated intron in the P. falciparum genes for histidine-rich proteins II and III. Mol Biochem Parasitol (1996) 0.92
Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. Exp Neurol (1998) 0.91
Transfer of genes into Plasmodium falciparum by polyamidoamine dendrimers. Mol Biochem Parasitol (1999) 0.91
Origin of the anomalous Fe-CO stretching mode in the CO complex of Ascaris hemoglobin. Biochemistry (2000) 0.91
On the scalability of parallel genetic algorithms. Evol Comput (1999) 0.90
Characterization of native falcipain, an enzyme involved in Plasmodium falciparum hemoglobin degradation. Mol Biochem Parasitol (1996) 0.90
The nature and frequency of neovascular age-related macular degeneration. Eur J Ophthalmol (2007) 0.89
Anger expression and incident hypertension. Psychosom Med (1999) 0.89
Transposition of the Drosophila element mariner within the human malaria parasite Plasmodium falciparum. Mol Biochem Parasitol (2000) 0.87
Estrogen receptors in skin appendage tumors and extramammary Paget's disease. Mod Pathol (1991) 0.87
Hydrogen bonding of tyrosine B10 to heme-bound oxygen in Ascaris hemoglobin. Direct evidence from UV resonance Raman spectroscopy. J Biol Chem (1996) 0.85
Calcium and the malaria parasite: parasite maturation and the loss of red cell deformability. Blood Cells (1991) 0.84
Components of sterol biosynthesis assembled on the oxygen-avid hemoglobin of Ascaris. Science (1992) 0.83
Novel gene structure and evolutionary context of Caenorhabditis elegans globin. Gene (1993) 0.83
The gambler's ruin problem, genetic algorithms, and the sizing of populations. Evol Comput (1999) 0.83
pS2 protein and steroid hormone receptors in invasive breast carcinomas. Int J Cancer (1992) 0.82
Naturally-occurring and recombinant forms of the aspartic proteinases plasmepsins I and II from the human malaria parasite Plasmodium falciparum. FEBS Lett (1999) 0.82
Caenorhabditis globin genes: rapid intronic divergence contrasts with conservation of silent exonic sites. J Mol Evol (1996) 0.82
The tyrosine B10 hydroxyl is crucial for oxygen avidity of Ascaris hemoglobin. J Biol Chem (1994) 0.81
Linkage problem, distribution estimation, and Bayesian networks. Evol Comput (2000) 0.81
Structural analysis of plasmepsin II. A comparison with human aspartic proteases. Adv Exp Med Biol (1998) 0.80
1H NMR investigation of the distal hydrogen bonding network and ligand tilt in the cyanomet complex of oxygen-avid Ascaris suum hemoglobin. J Biol Chem (1999) 0.80
Determinants of Ascaris hemoglobin octamer formation. J Biol Chem (1998) 0.79
Using previous models to bias structural learning in the hierarchical BOA. Evol Comput (2011) 0.79
Evaluation of a structure-based statine cyclic diamino amide encoded combinatorial library against plasmepsin II and cathepsin D. Bioorg Med Chem Lett (1998) 0.78